ONCOSTRATA Trademark

Trademark Overview

On Thursday, March 24, 2022, a trademark application was filed for ONCOSTRATA with the United States Patent and Trademark Office. The USPTO has given the ONCOSTRATA trademark a serial number of 79340715. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by OncoStrata Limited. The ONCOSTRATA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research in the field of oncology ; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; medical research; pharmaceutical research and development services; biotech research and development services; scientific analysis of clinical trials data; scientific analysis of clinical trials data for the purpose of producing clinical study protocols and safety summaries; advisory, information and consultancy services in the field of medical research
oncostrata

General Information

Serial Number79340715
Word MarkONCOSTRATA
Filing DateThursday, March 24, 2022
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7318035
Registration DateTuesday, March 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements

Goods and ServicesClinical research in the field of oncology ; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; medical research; pharmaceutical research and development services; biotech research and development services; scientific analysis of clinical trials data; scientific analysis of clinical trials data for the purpose of producing clinical study protocols and safety summaries; advisory, information and consultancy services in the field of medical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncoStrata Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameOncoStrata Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameOncoStrata Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, May 19, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022APPLICATION FILING RECEIPT MAILED
Monday, January 9, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023NON-FINAL ACTION WRITTEN
Wednesday, January 11, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 3, 2023REFUSAL PROCESSED BY MPU
Friday, March 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 29, 2023REFUSAL PROCESSED BY IB
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, September 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 18, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, November 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sunday, January 28, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Related Keywords

oncostrata research clinical trials scientific services medical data analysis pharmaceutical development